Clinical Trial Update: Efficacy and Safety of Extended-release Guanfacine Hydrochloride in Children and Adolescents Aged 6-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD) [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the efficacy and safety of extended-release guanfacine hydrochloride for children and adolescents with ADHD; results posted afte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• guanfacine hydrochloride (extended-release) (guanfacine hydrochloride)

Snippet

Sponsor: Shire | Conditions: Attention Deficit Hyperactivity Disorder | Phase 3 | Status: COMPLETED | Results posted: 2014-07-14